---
layout: page
title: Machine learning
sitemap: false
permalink: /machine_learning
---

In the rapidly evolving field of biomedical research, machine learning has emerged as a transformative tool that enhances our ability to analyze complex biological data. By leveraging algorithms that can learn from and make predictions based on data, researchers can uncover insights that were previously unattainable through traditional statistical methods. This capability is particularly crucial in understanding the complexities of diseases, guiding diagnosis, and developing targeted therapies.

Machine learning encompasses a wide range of techniques, broadly categorized into supervised and unsupervised learning methods. **Supervised learning** involves training a model on a labeled dataset, where the classes or outcomes are known. In the context of biomedical studies, this approach is invaluable for tasks such as classifying disease subtypes or predicting treatment outcomes based on gene expression data. For example, I have utilized supervised techniques like Linear Discriminant Analysis (LDA), Support Vector Machines (SVM), and Random Forest to analyze differentially expressed genes (DEGs) in various cancer types. These methods help to identify key features that distinguish between different subtypes, enabling more accurate diagnoses.

On the other hand, **unsupervised learning** provides an alternative approach that does not rely on pre-labeled data. Instead, it focuses on discovering hidden patterns or inherent structures within the data. Techniques such as hierarchical clustering and k-means clustering allow researchers to group samples based on similarities, revealing potential subtypes or novel classifications that may not have been previously identified. For instance, by applying these unsupervised methods to transcriptomic data, I have successfully identified clusters of cell lines that share similar gene expression profiles, facilitating a deeper understanding of the biological processes underlying disease mechanisms.

The integration of both supervised and unsupervised machine learning techniques in biomedical research leads to a comprehensive analysis of biological data. This dual approach not only enhances our understanding of disease processes but also aids in the discovery of potential therapeutic targets and biomarkers. The ability to predict patient outcomes based on gene expression data is particularly significant in the era of personalized medicine, where tailored treatment plans can be developed based on an individualâ€™s unique genetic makeup.

As an example of applying machine learning in biomedical studies, I utilized gene expression data from the transcriptomes of cancer patients to showcase its potential. However, the application of machine learning goes far beyond cancer research and transcriptomics. It can also be applied in areas such as genomics, proteomics, and pharmacogenomics to analyze the vast datasets generated by high-throughput technologies. As the volume of biological data continues to expand, machine learning will play an increasingly vital role in extracting meaningful insights and driving advancements in healthcare.

In summary, the combination of machine learning methods with **omics data** is revolutionizing biomedical research, providing powerful tools to classify diseases, identify important biological features, and ultimately improve patient outcomes.

Learn more about supervised machine learning methods and how they are applied in biomedical research to classify diseases and predict outcomes [here](https://vanngocthuyla.github.io/Data_Analysis/_pages/omics/supervised).

Explore unsupervised machine learning techniques used to discover hidden patterns in biological data and identify new disease subtypes [here](https://vanngocthuyla.github.io/Data_Analysis/_pages/omics/unsupervised).
